Novartis heart failure drug gets FDA incentives – Yahoo! New Zealand News
Economic Times |
Novartis heart failure drug gets FDA incentives
Yahoo! New Zealand News NEW YORK (AP) — Novartis AG said Friday its drug serelaxin, a treatment for acute heart failure, received breakthrough therapy status from the Food and Drug Administration. The drug is intended to treat symptoms of acute heart failure episodes … US FDA deems Novartis’ heart failure candidate a ‘breakthrough’PMLiVE FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030 …FierceBiotech Novartis Heart-Failure Drug Wins ‘Breakthrough’ Status at FDABusinessweek TheHeart.Org –DailyFinance all 13 news articles » |